Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

The morning catch up: Markets continue to fall on tricky data and China’s sell off

Published 07/07/2023, 09:50 am
Updated 07/07/2023, 10:00 am
© Reuters The morning catch up: Markets continue to fall on tricky data and China’s sell off
AUD/USD
-
UK100
-
XAU/USD
-
DJI
-
AXJO
-
XOM
-
GC
-
HG
-
LCO
-
ADP
-
TSLA
-
IXIC
-
FTEU3
-

The ASX will fall further today, with ASX 200 futures trading 90 points lower, down 1.28% as of 8:20 am AEST.

Yesterday, the ASX200 finished 90 points (-1.24%) lower at 7163, dragged down by Consumer Discretionary (-1.91%), Materials (-1.86%) and Financial (-1.45%) sectors. On the flipside, Utilities (-0.27%) and IT (+0.13%) outperformed.

IG Markets analyst Tony Sycamore noted several factors affecting markets.

“Wednesday’s China-inspired sell-off deepened yesterday as bond markets and higher yields rudely reclaimed the spotlight. In the US, the yield on the benchmark 10-year bond rose above 3.90% for the first time in four months – a move replicated locally as the yield on the Australian 10-year bond surged 10bp to 4.11%, its highest level since October.

“Falls in the interest-rate sensitive ASX200 Financial sector weighed heavily. NAB fell 2.11% to $25.96, ANZ fell 1.92% to $23.53, Macquarie fell 1.76% to $174.55, Westpac fell 1.72% to $21.15, and CBA fell 1.33% to $100.43.

“Following the overnight sell-off on Wall Street, the ASX200 is on track for a test of the bottom of its three-month trend channel, currently at 7050ish. Whether the ASX200 can stay above it (closing basis) will be the difference between further range trading in the weeks ahead or a test of year-to-date lows at 6900.”

Speaking of Wall St, the S&P500 is at risk of losing its July gains, threatened by the rally in yields and the possibility of a double top at 4500ish in the S&P500 and 15,285 in the Nasdaq.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Sycamore says, “After doing their best to ignore rising yields in recent weeks, US equity markets were left with nowhere to run last night as robust labour market data saw Treasury yields burst another 5-11bp higher across the curve.”

Further moving the markets was the ADP (NASDAQ:ADP) employment report which surged by 497,000 in June against the 225,000 expected. Continuing jobless claims rose by 1,720,000, the lowest in four months. Initial jobless claims rose by 248,000, well below a peak of 265,000 three weeks ago. Jobless claims fell by 496,000 to 9.824 million, below forecasts for a rise of 9.9 million but still well above pre-pandemic levels.

“Attention turns to tonight’s all-important Non-Farm payrolls release. The market is looking for payrolls to rise by 230,000 in June, easing from 339,000 in May. The unemployment rate is expected to fall to 3.6% from 3.7% in May. Average hourly earnings are expected to rise by 0.3% in June, allowing the annual rate to ease to 4.2% from 4.3%. If, any or more importantly, all readings are stronger than expected, it will likely ensure a very ugly end to the week for US stock markets,” Sycamore said.

What happened overnight?

Here’s what we saw (source Commsec):

US markets

Fell for a second day in a row amid a spike in US government bond yields after surprisingly strong US private sector hiring data from payroll processing firm ADP.

US companies added the most jobs in over a year in June, while other data showed the US services sector expanded in June at the fastest pace in four months. The figures fanned fears the US central bank will be aggressive in raising interest rates.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In company news, shares of oil major Exxon Mobil (NYSE:XOM) fell by 3.7% after forecasting a US$4 billion hit to earnings, while shares of some of the year’s best performers including chipmaker Nvidia and electric vehicle maker Tesla (NASDAQ:TSLA) slid by up to 2.1%. Shares of Moderna shed 4.3% after the pharma company announced a deal to develop mRNA drugs in China, despite rising Sino-US tensions.

At the close of trade, the Dow Jones index fell by 366 points or 1.1%. The S&P 500 index dipped by 0.8% and the Nasdaq index shed 113 points or 0.8%.

European markets

Slumped to 14-week lows on Thursday on global interest rate hike jitters after the release of robust US jobs data. Rate-sensitive real estate shares led losses with a 4.2% drop. Shares of gaming group Embracer fell by 13.8% after it raised US$182 million in a share issue directed to institutional investors. German factory orders rose by 6.4% in May (survey: +1%). The continent-wide FTSEurofirst 300 index fell by 2.3%. And the UK FTSE 100 index shed 2.2%, after hitting its lowest intraday level since March 20.

Currencies

Currencies were weaker against the US dollar in European and US trade.

  • The Euro fell from US$1.0899 to US$1.0834 and was near US$1.0890 at the US close.
  • The Aussie dollar dipped from US66.87 cents to US65.99 cents and was near US66.25 cents at the US close.
  • The Japanese yen eased from 143.56 yen per US dollar to JPY144.64 and was near JPY144.05 at the US close.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Commodities

Global oil prices were flat on Thursday as traders weighed tighter US crude supplies with the higher likelihood of a US rate hike that could dent energy demand. Crude inventories fell by 1.5 million barrels last week to 452.2 million barrels (survey: -1.0 million barrels).

  • Brent crude price fell by US13 cents or 0.2% to US$76.52 a barrel.
  • The US Nymex crude price added just US1 cent or less than 0.1% to US$71.80 a barrel.

  • The copper futures price slid 0.9%, under pressure from a weak global economic growth outlook and tepid demand in top consumer China.
  • The aluminium futures price dipped 0.8%.
  • The gold futures price fell by US$11.70 or 0.6% to US$1,915.40 an ounce. Spot gold was trading near US$1,910 an ounce at the US close.
  • Iron ore futures rose by US43 cents or 0.4% to US$112.27 a tonne on optimism about additional policy stimulus to support China's sputtering post-Covid economic rebound.

The S&P/ASX Small Ordinaries closed at 2,805.9 yesterday, down 1.27% yesterday.

Making news this morning, which you can read more about throughout the day with Proactive are:

  • Imugene Ltd announced that world-renowned independent cancer research and treatment centre City of Hope®, has confirmed the Phase I clinical trial of its oncolytic virotherapy candidate, CHECKvacc (HOV3, CF33-hNIS-anti-PDL1), will proceed to the fourth dose cohort.
  • Island Pharmaceuticals Ltd (ASX:ILA) has received grant research support for the planned ISLA-101 Phase 2a human clinical trial (PEACH study) in dengue fever.
  • 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • Race Oncology Ltd (ASX:RAC) shared an update on its preclinical and clinical programs, following significant progress in Australia and internationally through 2023.
  • AdAlta Ltd (ASX:1AD) released new data supporting the potential efficacy of AD-214 in human patients with Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic diseases, when administered using clinically feasible dosing regimens.
  • Established Australian copper-gold producer and explorer, Aeris Resources Ltd (ASX:AIS) provided an update on its FY23 production guidance.
  • Read more on Proactive Investors AU

    Disclaimer

    Latest comments

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.